Loading company…
Seoul-based S.Lab Asia provides biopharma logistics and cold chain services for sensitive products such as vaccines.
S.Lab Asia inc., founded in 2014 by Dave Han and headquartered in Seoul, South Korea, provides biopharma logistics and cold chain solutions for healthcare products such as vaccines and biological specimens. Its services include temperature-controlled transport and clinical trial logistics for clients in South Korea, the United States, Japan and Europe, working with pharmaceutical companies, hospitals and research institutions on a business-to-business basis. The company completed a Series B round of KRW 15 billion on December 28, 2021, led by Envisioning Partners and SKS Private Equity, with participation from Hyundai Motor Company and Korea Development Bank.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in